PROSENSA’S PRO044 DATA PRESENTED AT WMS BY DR. NATHALIE GOEMANS

Here are top line notes from the PRO044 presentation at World Muscle Society, Oct 4.

Age of inclusion:  5-16 Mean age:  9
The drug was well tolerated.
They saw trace dystrophin and reverant fibers pre- treatment.
18 subjects, 9 cohorts… SubQ delivery: .5mg/kg, 1.5mg/kg, 5mg/kg, 8mg/kg, 10mg/kg, 12mg/kg
IV delivery:  1.5mg/kg, 5mg/kg, 12mg/kg
5 weekly injections, 13 week follow up
Increase in dystrophin after 5 weeks:  SubQ delivery: 6 of 13 (46%),  IV delivery: 6 of 8 (75%)
Higher skipping efficiency than drisapersen
Extension study will use 6-9mg/kg.
No information on timing of next studies were given.

Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.

Donate